Conceptual and operational consistency in defining intestinal failure across randomized controlled trials: a systematic review and meta-research analysis
Authors:
- Kevin Fernando Montoya-QuinteroKMKevin Fernando Montoya-Quintero
- Sandra ValenciaSVSandra Valencia
- María Cristina Florián PérezMPMaría Cristina Florián Pérez
- Fabriccio J. Visconti-LopezFVFabriccio J. Visconti-Lopez
- Yadira Marín-HamburguerYMYadira Marín-Hamburguer
- Ivan David Lozada-MartinezILIvan David Lozada-Martinez
Open Access
- 21 January 2026
- journal article
- review article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Abstract
Intestinal failure (IF) is a rare but serious condition associated with high morbidity, mortality, and healthcare resource use. Although consensus-based deKeywords
This publication has 43 references indexed in Scilit:
- iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025Heart, Lung and Circulation, 2025
- ESPEN guideline on chronic intestinal failure in adults – Update 2023Clinical Nutrition, 2023
- Lipid strategies to prevent intestinal failure–associated liver disease in neonates: A pilot trialJournal of Parenteral and Enteral Nutrition, 2023
- Effects of glepaglutide, a long‐acting glucagon‐like peptide‐2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trialJournal of Parenteral and Enteral Nutrition, 2022
- Transcutaneous vagal nerve simulation to reduce a systemic inflammatory response syndrome and the associated intestinal failure: study protocol of a prospective, two-armed, sham-controlled, double-blinded trial in healthy subjects (the NeuroSIRS-Study)International Journal of Colorectal Disease, 2021
- Apraglutide, a novel glucagon‐like peptide‐2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo‐controlled, randomized phase 2 trialJournal of Parenteral and Enteral Nutrition, 2021
- Bile acid–farnesoid X receptor–fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trialJournal of Parenteral and Enteral Nutrition, 2021
- Effect of Glepaglutide, a Long‐Acting Glucagon‐Like Peptide‐2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized TrialJournal of Parenteral and Enteral Nutrition, 2020
- Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: results from a randomized clinical trialNutrition, 2018
- ESPEN guidelines on chronic intestinal failure in adultsClinical Nutrition, 2016